Overview

The Effect of PAP on ISSHL Comorbided With OSA

Status:
Recruiting

Trial end date:
2029-12-01

Target enrollment:

Participant gender:

Summary

This clinical randomized controlled study is to explore the effect of positive airway pressure(PAP) on patients in Beijing Tsinghua Changgung Hospital diagnosed with both idiopathic sudden sensorineural hearing loss comorbided(ISSHL) and obstructive sleep apnea(OSA) between Dec. 2019 to Dec. 2029.

Phase:

Phase 4

Details

Lead Sponsor:

Beijing Tsinghua Chang Gung Hospital

Treatments:

Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate